WHO ICTRP trial
Effect of carnitine supplementation on mental and physical well being of…
ACTRN12624000504516 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12624000504516 |
|---|---|
| Public title | Effect of carnitine supplementation on mental and physical well being of patients on haemodialysis for end stage kidney disease |
| Scientific title | Effect of levocarnitine supplementation on quality of life amongst patients on maintenance haemodialysis for end stage renal disease |
| Primary sponsor | Dr. Obaid Ur Rehman, Pak Emirates Military Hospital Rawalpindi Pakistan |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Pakistan |
| Conditions | End stage renal disease; End stage renal disease;Renal and Urogenital - Kidney disease |
| Interventions | Levocarnitine 1 gram (diluted to 20ml with normal saline) will be administered into the venous port of dialysis circuit/ tubing, slowly over 3- 5 minutes within the first 15 minutes of starting each haemodialysis session. This would be done… |
| Registration date | Apr 24, 2024 |
| Target size | 24 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: